Heart Rate and Cardiovascular Diseases Prognosis in People With Stable Coronary Artery Disease
NCT ID: NCT02244853
Last Updated: 2014-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
51703 participants
OBSERVATIONAL
2013-09-30
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Heart Rate and Initial Presentation of Cardiovascular Diseases (Caliber)
NCT01947361
Serum Uric Acid Levels and Onset of Cardiovascular Diseases: a CALIBER Study
NCT03425305
Ethnicity and Onset of Cardiovascular Disease: A CALIBER Study
NCT02176174
Social Deprivation and Initial Presentation of 12 Cardiovascular Diseases: a CALIBER Study
NCT01937065
An Observational Study of Natural History of Cardiovascular Diseases
NCT02077023
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* No heart rate measurement after their 'index date' of eligibility to entry the study
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wellcome Trust
OTHER
National Institute for Health Research, United Kingdom
OTHER_GOV
University College, London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Harry Hemingway
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Harry Hemingway, Professor
Role: STUDY_DIRECTOR
Farr Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Farr Institute, University College London
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
086091/Z/08/Z
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
RP-PG-0407-10314
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
12_153R_IP24
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.